GR20090100230A - Απο του στοματος εναιωρημα οξικης δεξαμεθανοζης-συνθεση καλυψης γευσης της δεξαμεθανοζης - Google Patents
Απο του στοματος εναιωρημα οξικης δεξαμεθανοζης-συνθεση καλυψης γευσης της δεξαμεθανοζηςInfo
- Publication number
- GR20090100230A GR20090100230A GR20090100230A GR20090100230A GR20090100230A GR 20090100230 A GR20090100230 A GR 20090100230A GR 20090100230 A GR20090100230 A GR 20090100230A GR 20090100230 A GR20090100230 A GR 20090100230A GR 20090100230 A GR20090100230 A GR 20090100230A
- Authority
- GR
- Greece
- Prior art keywords
- dexamethasone
- dexamethasone acetate
- bad taste
- pharmaceutically acceptable
- drastic
- Prior art date
Links
- FPVRUILUEYSIMD-RPRRAYFGSA-N [(8s,9r,10s,11s,13s,14s,16r,17r)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] acetate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(OC(C)=O)[C@@]1(C)C[C@@H]2O FPVRUILUEYSIMD-RPRRAYFGSA-N 0.000 title abstract 4
- 229960003657 dexamethasone acetate Drugs 0.000 title abstract 4
- 206010013911 Dysgeusia Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000000873 masking effect Effects 0.000 title 1
- 229940100692 oral suspension Drugs 0.000 title 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 2
- 239000008135 aqueous vehicle Substances 0.000 abstract 2
- 229960003957 dexamethasone Drugs 0.000 abstract 2
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 abstract 1
- -1 dexamethasone ester Chemical class 0.000 abstract 1
- 239000010419 fine particle Substances 0.000 abstract 1
- 235000011187 glycerol Nutrition 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229940124531 pharmaceutical excipient Drugs 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20090100230A GR20090100230A (el) | 2009-04-14 | 2009-04-14 | Απο του στοματος εναιωρημα οξικης δεξαμεθανοζης-συνθεση καλυψης γευσης της δεξαμεθανοζης |
| PCT/GR2010/000018 WO2010119300A2 (en) | 2009-04-14 | 2010-04-14 | Oral suspension of dexamethasone acetate -taste masking composition of dexamethasone |
| EP10719774A EP2477604A2 (de) | 2009-04-14 | 2010-04-14 | Orale supension einer dexamethasonacetat-geschmacksmaskierenden zusammensetzung aus dexamethason |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20090100230A GR20090100230A (el) | 2009-04-14 | 2009-04-14 | Απο του στοματος εναιωρημα οξικης δεξαμεθανοζης-συνθεση καλυψης γευσης της δεξαμεθανοζης |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR20090100230A true GR20090100230A (el) | 2010-11-18 |
Family
ID=42269791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR20090100230A GR20090100230A (el) | 2009-04-14 | 2009-04-14 | Απο του στοματος εναιωρημα οξικης δεξαμεθανοζης-συνθεση καλυψης γευσης της δεξαμεθανοζης |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP2477604A2 (de) |
| GR (1) | GR20090100230A (de) |
| WO (1) | WO2010119300A2 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101368587B1 (ko) | 2010-12-27 | 2014-03-05 | 주식회사 삼양바이오팜 | 오심 또는 구토 방지용 조성물 |
| WO2013149258A2 (en) | 2012-03-30 | 2013-10-03 | Charles Drew University of Medicine and Science | Compositions and methods for treating or preventing metabolic syndrome disorders |
| US20140271923A1 (en) | 2013-03-14 | 2014-09-18 | Christopher Brian Reid | Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions |
| US10537585B2 (en) | 2017-12-18 | 2020-01-21 | Dexcel Pharma Technologies Ltd. | Compositions comprising dexamethasone |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2159195A1 (en) * | 1971-11-10 | 1973-06-22 | Fabre Sa Pierre | Compsns contg sorbitol and a corticoid or pyrazolone - - suppression of ulcerogenic effects |
| US3962430A (en) * | 1974-08-07 | 1976-06-08 | Merck & Co., Inc. | Sterilization of solid non-electrolyte medicinal agents employing sodium chloride |
| US6066292A (en) * | 1997-12-19 | 2000-05-23 | Bayer Corporation | Sterilization process for pharmaceutical suspensions |
| NZ551336A (en) | 2004-04-22 | 2010-04-30 | Acucort Ab | Pharmaceutical compositions for acute glucocorticoid therapy |
| DK2486942T3 (en) | 2004-11-24 | 2019-01-28 | Meda Pharmaceuticals Inc | COMPOSITIONS CONTAINING AZELASTINE AND PROCEDURES FOR USING IT |
| DE102005055385A1 (de) | 2004-12-09 | 2006-06-14 | Bayer Healthcare Ag | Arzneimittel zur hygienischen Applikation im Ohr |
| KR101217680B1 (ko) * | 2004-12-09 | 2013-01-02 | 바이엘 인텔렉쳐 프로퍼티 게엠베하 | 산을 사용한 글루코코르티코이드 에스테르의 안정화 |
| US8468589B2 (en) | 2006-01-13 | 2013-06-18 | Fortinet, Inc. | Computerized system and method for advanced network content processing |
| JP2009518395A (ja) | 2005-12-09 | 2009-05-07 | テバ ファーマシューティカル インダストリーズ リミティド | 難溶性化合物の水性分散物および溶液ならびにそれらの調製方法 |
| CN101190177B (zh) * | 2006-11-24 | 2010-09-01 | 上海医药工业研究院 | 醋酸地塞米松局部成膜凝胶组合物及其应用 |
-
2009
- 2009-04-14 GR GR20090100230A patent/GR20090100230A/el active IP Right Revival
-
2010
- 2010-04-14 WO PCT/GR2010/000018 patent/WO2010119300A2/en not_active Ceased
- 2010-04-14 EP EP10719774A patent/EP2477604A2/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010119300A2 (en) | 2010-10-21 |
| WO2010119300A3 (en) | 2011-03-24 |
| EP2477604A2 (de) | 2012-07-25 |
| WO2010119300A9 (en) | 2011-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2607892C2 (ru) | Композиции на основе ксилита, препятствующие отделению слизи, а также смежные способы и композиции | |
| WO2005115339A2 (en) | Composition for enhancing absorption of a drug and method | |
| GB0814302D0 (en) | Compounds and methods | |
| HRP20200991T1 (hr) | Modulator androgenog receptora u kombinaciji s abirateron acetatom i prednizonom za liječenje karcinoma prostate | |
| MD20150050A2 (ro) | Soluţii midriatice şi antiinflamatorii stabile fără conservanţi pentru injectare | |
| WO2013022783A3 (en) | Progesterone containing oral dosage forms and related methods | |
| NZ737862A (en) | High-concentration monoclonal antibody formulations | |
| WO2011160136A3 (en) | Progesterone containing oral dosage forms and related methods | |
| HRP20220929T3 (hr) | Sastav za inhalaciju koji sadrži aklidinij za liječenje astme | |
| MX2011012043A (es) | Sistema farmaceutico para suministro transmembrana. | |
| MX2015015589A (es) | Composiciones y metodos para el suministro de agentes activos hidrófobos. | |
| HRP20151337T1 (hr) | Farmaceutski oblik doziranja koji sadrži 6'-fluoro-(n-metil- ili n,n-dimetil)-4-fenil-4',9'-dihidro-3'h-spiro[cikloheksan-1,1'-pirano[3,4,b]indol]-4-amin | |
| WO2006039692A3 (en) | Modified release ibuprofen dosage form | |
| PH12012502085A1 (en) | Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same | |
| RU2018136872A (ru) | Композиции, содержащие 15-oh эпк, и способы их применения | |
| RU2017111503A (ru) | КОМПОЗИЦИИ(17-β)-3-ОКСОАНДРОСТ-4-ЕН-17-ИЛ УНДЕКАНОАТА И СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ | |
| MX2009012782A (es) | Formulaciones para administracion oral de agentes terapeuticos y metodos relacionados. | |
| NZ714517A (en) | Delayed release cysteamine bead formulation | |
| MX2025001734A (es) | Formas farmacéuticas sólidas orales que contienen cannabinoides | |
| RU2011138178A (ru) | рН-МОДУЛИРОВАННЫЕ СОСТАВЫ ДЛЯ ДОСТАВКИ В ЛЕГКИЕ | |
| WO2010119300A9 (en) | Oral suspension of dexamethasone acetate -taste masking composition of dexamethasone | |
| AU2014226192A8 (en) | Dry pharmaceutical compositions comprising active agent nanoparticles bound to carrier particles | |
| RU2015150303A (ru) | Композиция, содержащая гидрокортизон | |
| TW200509985A (en) | Drug delivery system for sub-Tenon administration of fine particles | |
| JP2012524772A (ja) | ジヒドロアルテミシニンを含む舌下スプレー用製剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MF | Right revoked (revocation) |
Effective date: 20111107 |
|
| ML | Lapse due to non-payment of fees |
Effective date: 20111102 |
|
| ML | Lapse due to non-payment of fees |
Effective date: 20121102 |
|
| NF | Restoration of lapsed right |
Effective date: 20120117 |